Blood lead level: an overlooked risk of carpal tunnel syndrome in hemodialysis patients

References

• Bansal VK, Bansal S. Nervous system disorders in dialysis patients. Handb Clin Neurol. 2014;119:395–404.
   PubMedGoogle Scholar
• Bicknell JM, Lim AC, Raroque HG Jr., et al. Carpal tunnel syndrome, subclinical median mononeuropathy, and peripheral polyneuropathy: common early complications of chronic peritoneal dialysis and hemodialysis. Arch Phys Med Rehabil. 1991;72:378–381.
   PubMed Web of Science ®Google Scholar
• Himmelfarb J, Stenvinkel P, Ikizler TA, et al. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002;62:1524–1538.
   PubMed Web of Science ®Google Scholar
• Cofan F, Garcia S, Combalia A, et al. Carpal tunnel syndrome secondary to uraemic tumoral calcinosis. Rheumatology (Oxford). 2002;41:701–703.
   PubMed Web of Science ®Google Scholar
• Delmez JA, Holtmann B, Sicard GA, et al. Peripheral nerve entrapment syndromes in chronic hemodialysis patients. Nephron. 1982;30:118–123.
   PubMed Web of Science ®Google Scholar
• Kimura I, Sekino H, Ayyar DR, et al. Carpal tunnel syndrome in patients on long-term hemodialysis. Tohoku J Exp Med. 1986;148:257–266.
   PubMed Web of Science ®Google Scholar
• Krachler M, Wirnsberger GH. Long-term changes of plasma trace element concentrations in chronic hemodialysis patients. Blood Purif. 2000;18:138–143.
   PubMed Web of Science ®Google Scholar
• Kessler M, Durand PY, Huu TC, et al. Mobilization of lead from bone in end-stage renal failure patients with secondary hyperparathyroidism. Nephrol Dial Transplant. 1999;14:2731–2733.
   PubMed Web of Science ®Google Scholar
• Lin JL, Lin-Tan DT, Hsu CW, et al. Association of blood lead levels with mortality in patients on maintenance hemodialysis. Am J Med. 2011;124:350–358.
   PubMed Web of Science ®Google Scholar
• Lin JL, Lin-Tan DT, Yen TH, et al. Blood lead levels, malnutrition, inflammation, and mortality in patients with diabetes treated by long-term hemodialysis. Am J Kidney Dis. 2008;51:107–115.
   PubMed Web of Science ®Google Scholar
• Chang FC, Lin YP. Survey of lead concentration in tap water on a university campus. Environ Sci Pollut Res. 2019;26:25275.
   PubMed Web of Science ®Google Scholar
• Hsu DJ, Chung SH, Dong JF, et al. Water-based automobile paints potentially reduce the exposure of refinish painters to toxic metals. Int J Environ Res Public Health. 2018;15:899.
   Web of Science ®Google Scholar
• Ko YC. Air pollution and its health effects on residents in Taiwanese communities. Kaohsiung J Med Sci. 1996;12:657–669.
   PubMedGoogle Scholar
• Wang JD, Soong WT, Chao KY, et al. Occupational and environmental lead poisoning: case study of a battery recycling smelter in Taiwan. J Toxicol Sci. 1998;23(Suppl 2): 241–245.
   PubMedGoogle Scholar
• Lin JL, Lin-Tan DT, Chen KH, et al. Blood lead levels association with 18-month all-cause mortality in patients with chronic peritoneal dialysis. Nephrol Dial Transplant. 2010;25:1627–1633.
   PubMed Web of Science ®Google Scholar
• Morena M, Delbosc S, Dupuy AM, et al. Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation. Hemodial Int. 2005;9:37–46.
   PubMedGoogle Scholar
• Yao Q, Pecoits-Filho R, Lindholm B, et al. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease. Scand J Urol Nephrol. 2004;38:405–416.
   PubMed Web of Science ®Google Scholar
• Lin JL, Lin-Tan DT, Hsu KH, et al. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. N Engl J Med. 2003;348:277–286.
   PubMed Web of Science ®Google Scholar
• Lin JL, Tan DT, Ho HH, et al. Environmental lead exposure and urate excretion in the general population. Am J Med. 2002;113:563–568.
   PubMed Web of Science ®Google Scholar
• Weng CH, Hu CC, Yen TH, et al. Association between environmental particulate matter and carpal tunnel syndrome in patients undergoing hemodialysis. Kidney Blood Press Res. 2017;42:827–836.
   PubMed Web of Science ®Google Scholar
• Ellender G, Sewell DK, Ham KN, et al. Lead-loaded ion-exchange resin bead as a calcergen. Calcif Tissue Res. 1978;26:253–258.
   PubMedGoogle Scholar
• Gilbert MS, Robinson A, Baez A, et al. Carpal tunnel syndrome in patients who are receiving long-term renal hemodialysis. J Bone Joint Surg Am. 1988;70:1145–1153.
   PubMedGoogle Scholar
• Matsuo K, Ikizler TA, Hoover RL, et al. Transforming growth factor-beta is involved in the pathogenesis of dialysis-related amyloidosis. Kidney Int. 2000;57:697–708.
   PubMed Web of Science ®Google Scholar
• Cheng YJ, Liu MY. Modulation of tumor necrosis factor-alpha and oxidative stress through protein kinase C and P42/44 mitogen-activated protein kinase in lead increases lipopolysaccharide-induced liver damage in rats. Shock. 2005;24:188–193.
   PubMed Web of Science ®Google Scholar
• Jomova K, Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology. 2011;283:65–87.
   PubMed Web of Science ®Google Scholar
• Huang YC, Chang WC, Shan YH, et al. Toxic metals increase serum tumor necrosis factor-alpha levels, modified by essential elements and different types of tumor necrosis factor-alpha promoter single-nucleotide polymorphisms. Epidemiology. 2017;28: S113–S120.
   PubMed Web of Science ®Google Scholar
• Li N, Liu X, Zhang P, et al. The effects of early life lead exposure on the expression of interleukin (IL) 1beta, IL-6, and glial fibrillary acidic protein in the hippocampus of mouse pups. Hum Exp Toxicol. 2015;34:357–363.
   PubMed Web of Science ®Google Scholar
• Beier EE, Sheu TJ, Dang D, et al. Heavy metal ion regulation of gene expression: mechanisms by which lead inhibits osteoblastic bone-forming activity through modulation of the Wnt/β-catenin signaling pathway. J Biol Chem. 2015;290:18216–18226.
   PubMed Web of Science ®Google Scholar
• Holz JD, Beier E, Sheu TJ, et al. Lead induces an osteoarthritis-like phenotype in articular chondrocytes through disruption of TGF-β signaling. J Orthop Res. 2012;30:1760–1766.
   PubMed Web of Science ®Google Scholar
• Kolaja KL, Klaassen CD. Dose-response examination of UDP-glucuronosyltransferase inducers and their ability to increase both TGF-beta expression and thyroid follicular cell apoptosis. Toxicol Sci. 1998;46:31–37.
   PubMed Web of Science ®Google Scholar
• Kasten-Jolly J, Heo Y, Lawrence DA. Central nervous system cytokine gene expression: modulation by lead. J Biochem Mol Toxicol. 2011;25:41–54.
   PubMed Web of Science ®Google Scholar
• Wu WT, Tsai PJ, Yang YH, et al. Health impacts associated with the implementation of a national petrol-lead phase-out program (PLPOP): evidence from Taiwan between 1981 and 2007. Sci Total Environ. 2011;409:863–867.
   PubMed Web of Science ®Google Scholar
• Pirkle JL, Brody DJ, Gunter EW, et al. The decline in blood lead levels in the United States. The National Health and Nutrition Examination Surveys (NHANES). JAMA. 1994;272:284–291.
   PubMed Web of Science ®Google Scholar
• Heard MJ, Chamberlain AC. Uptake of Pb by human skeleton and comparative metabolism of Pb and alkaline earth elements. Health Phys. 1984;47:857–865.
   PubMed Web of Science ®Google Scholar
• Chen KH, Lin JL, Lin-Tan DT, et al. Effect of chelation therapy on progressive diabetic nephropathy in patients with type 2 diabetes and high-normal body lead burdens. Am J Kidney Dis. 2012;60:530–538.
   PubMed Web of Science ®Google Scholar